Reinhard Ilk
Vienna, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Clinical efficacy of SARS-CoV-2 Omicron-neutralizing antibodies in immunoglobulin preparations for the treatment of agammaglobulinemia in patients with primary antibody deficiency.
Journal: Journal of medical virology
Published: March 28, 2024
In vitro field study and worldwide survey assessing how clinical haemostasis laboratories analyse recombinant and plasma-derived von Willebrand factor products.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: May 24, 2023
Rapidly Increasing Severe Acute Respiratory Syndrome Coronavirus 2 Neutralization by Intravenous Immunoglobulins Produced From Plasma Collected During the 2020 Pandemic.
Journal: The Journal of infectious diseases
Published: February 12, 2021
Development of an In Vitro Biopotency Assay for an AAV8 Hemophilia B Gene Therapy Vector Suitable for Clinical Product Release.
Journal: Molecular therapy. Methods & clinical development
Published: February 19, 2020
Molecular Basis of the Divergent Immunogenicity of Two Pediatric Tick-Borne Encephalitis Virus Vaccines.
Journal: Journal of virology
Published: November 25, 2015
Neuraminidase-Inhibiting Antibody Response to H5N1 Virus Vaccination in Chronically Ill and Immunocompromised Patients.
Journal: Open forum infectious diseases
Published: June 19, 2014
A vero cell-derived whole-virus H5N1 vaccine effectively induces neuraminidase-inhibiting antibodies.
Journal: The Journal of infectious diseases
Published: November 18, 2011
Showing 1-9 of 9
Last Updated: 09/26/2026